HOME >> MEDICINE >> NEWS
Low tar cigarettes do not cut lung cancer risk

The risk of lung cancer is no different in people who smoke medium tar cigarettes, low tar cigarettes, or very low tar cigarettes, concludes new research from the United States.

Researchers analysed the relation between the tar rating of the brand of cigarette smoked in 1982 and death from lung cancer over six years among 364,239 men and 576,535 women aged 30 years or more.

Irrespective of the tar level of their current brand, all current smokers had a far greater risk of lung cancer than people who had never smoked or who had quit.

Men and women who smoked very low tar (7 mg or less) and low tar (8-14 mg) brands had risks of lung cancer indistinguishable from those who smoked medium tar (15-21 mg) brands. This pattern did not change after demographic factors, dietary habits, and occupational and medical histories were taken into account.

Men and women who smoked non-filtered cigarettes with tar ratings of 22 mg or more had even higher risks of lung cancer.

These findings are consistent with other evidence that people smoke low tar cigarettes more intensively, and challenge the assumption that the link between tar rating and lung cancer risk is necessarily linear, say the authors.

They suggest that reducing the use of high tar non-filter cigarettes may provide limited public health benefits in those countries where these products are commonly used.


'"/>

Contact: Linda Millington
pressoffice@bma.org.uk
44-0-20-7383-6473
BMJ-British Medical Journal
8-Jan-2004


Page: 1

Related medicine news :

1. Tobacco-company-sponsored parties with free cigarettes may encourage students to start smoking
2. Majority of cigarettes in the US smoked by nicotine-dependent or psychiatrically ill persons
3. Activism prompts teen smokers to cut back on cigarettes, Stanford study finds
4. Heavy smokers see cigarettes as friends
5. UNC study shows Internet offers youths easy way to buy cigarettes
6. Rising cost of cigarettes may help smokers honor new years resolution to quit
7. Carcinogen in cigarettes causes mutation linked to lung cancer
8. Brain chemicals can thwart desire to smoke cigarettes
9. It is easy for adolescents to purchase cigarettes illegally in North Carolina
10. Hormonal treatment improves survival in high-risk prostate cancer patients
11. International breast cancer prevention study launches in the United States and Canada

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Low tar cigarettes not cut lung cancer risk

(Date:7/30/2014)... Neil Haley, the Total Tutor host of ... to find out about what is branding, how am I ... , Reynolds is an original founding member of the company ... and CEO of Simply G Media. He has written a ... holds the distinction of completing the Dale Brown and Project ...
(Date:7/30/2014)... Pain Free Living web: Superior Magnetics ... relief and improved performance. This new magnetic sports bracelet ... silicone core that is sheathed in nylon soaked in ... with scalar energy and Schumann frequency thus making it ... 12 years experience developing magnetic bracelets. We developed the ...
(Date:7/29/2014)... Paul Mata, CEO of ‘Create Indestructible Wealth,’ ... 30 Days” E-book. The e-book includes a myriad of fast ... cash. Examples include downloading and utilizing specific phone apps ... people monetize the assets they didn't know they had like ... find in their garage. , After reading the e-book, ...
(Date:7/29/2014)... 1Heart Caregiver Services’ advocacy on ... on Brain Fitness Education brings great acceptance from ... Program Director Tee Barr delivered an exceptional Brain ... and the Assisted Living section of Aegis Ventura ... Christy Rozsa and Aegis Life Neighborhood Director Christine ...
(Date:7/29/2014)... July 29, 2014 Daily Gossip indicates ... as all other disturbing symptoms that hemorrhoids commonly causes. ... researcher and natural medicine expert. , The author ... to the elimination of symptoms such as itching, burning, ... Learn more about the H Miracle by visiting the ...
Breaking Medicine News(10 mins):Health News:Entrepreneur and Vi Millioniare GJ Reynolds Discusses How to Improve Your Brand on the Simply G Radio Show, a Division of the Simply G Media Network 2Health News:Superior Magnetics Released New Magnetic Sports Bracelet for Pain 2Health News:Create Indestructible Wealth Launches Innovative E-Book: “Realistic Ways to Make More Money in 30 Days” 2Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 2Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 3Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 4Health News:H Miracle Review Exposes Natural Method to Cure Hemorrhoids 2
(Date:7/30/2014)... YORK , July 30, 2014 ACCESS ... for oncology supportive care, announced that its novel product ... in an article on OncLive.com titled, "Study Finds Mouth ... Cancers."  Dr. Steve Sonis , a leading expert ... seen in the oncology community for evidence-based strategies for ...
(Date:7/30/2014)... ANTONIO , July 30, 2014   ... company focused on innovating lifesaving devices and methods ... $4.5 million in Series A financing, which was ... Proceeds from the deal will allow Bluegrass Vascular ... Access Catheter System, enhance manufacturing capabilities, and proceed ...
(Date:7/29/2014)... Israel , July 30, 2014  Immune ... Stockholm : "IMNP."; "Immune" or "the ... of patients for a Phase II proof of concept ... in the treatment of moderate to severe bullous pemphigoid. ... receive two bertilimumab infusions, at a dose of 10 ...
Breaking Medicine Technology:Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3Bluegrass Vascular Technologies Raises $4.5M Series A Financing Led By Targeted Technology Funds 2Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 2Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 3Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 4Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 5
Cached News: